Raw Data for "A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer"

Published: 24 June 2024| Version 1 | DOI: 10.17632/x29rjbpk8r.1
Contributors:
Juan Wei, Sheyu Zhang

Description

This file contains the following raw data for "A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer"

Files

Categories

Biologicals

Licence